Gesynta Pharma Reaches Key Recruitment Milestone i...
Category : Clinical Trial Update 18 June 2026Gesynta Pharma AB, a Swedish clinical-stage pharmaceutical company focused on chronic inflammatory d...
Clinical Trial Update
Lundbeck Reports Encouraging Phase II Results for...
Category : Clinical Trial Update 17 June 2026Lundbeck Shares New Clinical Data at ENDO 2026 Biopharmaceutical company Lundbeck has announced p...
Istesso Begins Phase 2 Trial of Leramistat for Mus...
Category : Clinical Trial Update 17 June 2026Istesso Advances Lead Drug Candidate into Phase 2 Testing IP Group plc has announced that its por...
PleoPharma to Present New Cannabis Withdrawal Rese...
Category : Clinical Trial Update 16 June 2026PleoPharma has announced that it will present two scientific posters at the College on Problems of D...
Neurocrine Biosciences Shares New Long-Term Data f...
Category : Clinical Trial Update 16 June 2026Neurocrine Biosciences has announced new late-breaking data from the Phase 3 development program of...
Latest Newsletter Post
-
Agomab Unveils Phase 2b Study Desig..
24 June 2026
-
CureGene Doses First Patient in US..
24 June 2026
-
MoonLake Reports Strong One-Year Ph..
24 June 2026
-
uniQure Reports Early Clinical Data..
23 June 2026
-
AbbVie to Acquire Apogee Therapeuti..
23 June 2026
